Introduction: Guangzhou Regenex Pharmaceutical Co., Ltd. (Regenex) is a high-tech pharmaceutical company focusing on the research and development, production and sales of reproductive health drugs, chronic disease drugs and external drugs. enterprise.
The company was founded in 2003 and is located in Guangzhou Science City, a famous high-tech industrial park in China with beautiful scenery. It was founded by Dr. Lu Zhijun, a returnee from the United States. The factory has a construction area of ??26,362 square meters and currently has more than 500 employees, including more than 250 marketing personnel and more than 90 R&D personnel.
Danmei (levonorgestrel enteric-coated tablets), which was launched by the company in 2008 and has independent intellectual property rights in the field of birth control, has passed the 2010 new version of GMP certification, and the product has been awarded the "Guangzhou Famous Trademark" "title.
The company's marketing center adheres to the concept of "customer first, all-staff marketing" and adopts a enterprising attitude to establish an effective and innovative new business model of marketing, promotion and brand collaborative development in the Chinese pharmaceutical market. Implement GPS track management for marketing personnel, implement terminal standard marketing methods for marketing, and implement 7-16 hours of high-quality customer service follow-up with professional background after sales. At present, the marketing center has trained nearly 100 senior regional managers and market managers, as well as nearly 500 professional marketing, promotion and marketing personnel. It has established partnerships with more than 150 dealers across the country, and its sales network covers the entire country. China.
The company's R&D center adheres to the R&D strategy of "original development and systematic innovation", aims at the research and development of new drugs, takes drug research and development in the field of reproductive health as its main direction, and integrates information, scientific research and pilot testing. In one, there are currently 40 new drug projects under research. It has undertaken more than 20 national, provincial and municipal science and technology projects, and applied for 20 invention patents (1 US patent), 10 of which have been authorized. The R&D center has successfully built technology platforms such as chiral drug synthesis, injection of long-acting liposome targeted drug delivery systems, oral sustained and controlled release drug delivery systems, poorly soluble drug immediate release systems, and rapid analysis of complex systems. It has achieved domestic leading technical advantages in health, high-end latex products, nutrition and health care and other subdivisions. Its comprehensive strength in new drug research and development has ranked at the leading level in South China. It has been approved as a pilot platform for steroid hormone preparations in Guangdong Province and a key enterprise in Guangzhou. Laboratory and Guangzhou Enterprise Technology Center, and won the Guangzhou Science and Technology Progress Award.
Langsheng Pharmaceutical adheres to the corporate mission of "making human reproduction healthier", practices the corporate culture of "value, efficiency and pleasure", and advocates that personal value be reflected in the process of realizing corporate value and customer value. value concept. In the future development process, the company will continue to develop high-tech products, expand business areas, and achieve another take-off of the enterprise.
Legal representative: Lu Zhijun
Date of establishment: 2003-08-05
Registered capital: RMB 23.872602 million
Region : Guangdong Province
Unified Social Credit Code: 91440116751987037T
Business status: Operating (opening) enterprise
Industry: Manufacturing
Company type: Limited liability company (natural person investment or holding)
English name: Regenex Pharmaceuticals, Ltd.
Staff size: 500-999 people
Enterprise Address: No. 3 Jinfengyuan Road, Science City, Guangzhou High-tech Industrial Development Zone
Business scope: biotechnology development services; biotechnology transfer services; chemical pharmaceutical preparation manufacturing; wholesale of Western medicine; retail of pharmaceuticals; wholesale of prepackaged food ;Health food manufacturing;